NIHCR Policy Analysis No. 3
October 2010
Emily Carrier, Hoangmai H. Pham, Eugene C. Rich
Determining what treatments work best for which patients in real-world settings—known as comparative effectiveness research (CER)—can help foster beneficial medical innovation, according to a new Policy Analysis from the nonprofit, nonpartisan National Institute for Health Care Reform (NIHCR).
Written by researchers at the Center for Studying Health System Change (HSC) and Mathematica Policy Research, the analysis identifies key policy considerations to help ensure that CER encourages beneficial innovation while strengthening the evidence base for medical decisions.
This article is available at the National Institute for Health Care Reform Web site.